|1.||Ignacimuthu, Savarimuthu: 5 articles (04/2014 - 08/2008)|
|2.||Islam, Md Shahidul: 4 articles (12/2015 - 03/2008)|
|3.||Cherrington, Alan D: 4 articles (06/2015 - 04/2004)|
|4.||Wu, Xiangyang: 3 articles (11/2015 - 12/2011)|
|5.||Zhao, Ting: 3 articles (11/2015 - 12/2011)|
|6.||Yang, Liuqing: 3 articles (11/2015 - 12/2011)|
|7.||Mao, Guanghua: 3 articles (11/2015 - 12/2011)|
|8.||Sharma, Sunil: 3 articles (09/2013 - 01/2012)|
|9.||Vasudeva, Neeru: 3 articles (09/2013 - 01/2012)|
|10.||Irimia, Jose M: 3 articles (01/2013 - 04/2010)|
|1.||Body Weight (Weight, Body)
05/22/2007 - "An improvement of hepatic glycogen, a decrease of liquid and food intake, and a significantly positive actions in the weight of skeletal muscles (soleus and extensor digitorum longus) and kidneys were also observed, but just diabetic group treated with WSF at a dose of 125 mg/kg showed significant reduction in urinary volume, body weight, an improvement of epididymal adipose tissue and a positive action in liver weight. "
01/01/2011 - "The extract also improved body weight and promoted liver glycogen content. "
12/01/2003 - "Fenugreek leaves improved the body weight and liver glycogen. "
04/01/2005 - "The present study examined the time course of effects of two formulations of the Toximul (Tox) class of anionic/nonionic IS on body weights and liver glycogen (+/-virus) during early development. "
01/01/2015 - "The survival rate, body weight, organ weight, liver glycogen and blood parameters (RBC and Hb) were also measured. "
08/01/2005 - "Inhibition of hepatic glycogen phosphorylase is a promising treatment strategy for attenuating hyperglycemia in type 2 diabetes. "
05/01/1949 - "Studies in hepatic glycogen storage; adrenalin-induced hyperglycemia as an index of liver function."
11/01/2013 - "Hypercortisol induced both glycogenesis and gluconeogenesis resulting in hyperglycemia and muscle and liver glycogen deposition, most likely as a protective mechanism for prolonged stress situations and primarily fuelled by protein mobilization. "
05/30/2012 - "EB reduced hyperglycemia and increased hepatic glycogen content in animals exposed to DI. "
01/01/2012 - "At 4 h following administration, there was normalization of hyperglycemia and hypercorticosteronemia, marginal attenuation of liver TAT activity and marked increase in liver glycogen content, without spontaneous reactivation of AChE activity in the organs studied. "
05/01/2015 - "This is directly related to insulin resistance, although liver glycogen storage is normal. "
01/01/2015 - "However, the effects of 4-HIL on liver glycogen synthesis and hepatic insulin resistance have not been described. "
04/01/2014 - "Finally, MA treatment of mice fed with a high-fat diet reduced the model-associated adiposity and insulin resistance, and increased the accumulated hepatic glycogen content. "
11/01/2011 - "Cinnamon increases liver glycogen in an animal model of insulin resistance."
01/01/2009 - "The treatment of GPE80 could significantly reduce the index of insulin resistance (HOMA-IR) and increase hepatic glycogen concentration, compared with HFD group (P < 0.05). "
04/01/1985 - "Fetal hypoinsulinaemia was associated, however, with a marked decrease in fetal liver glycogen together with a decrease in fetal liver weight, which was more pronounced than the decrease in fetal body weight. "
02/01/2010 - "Both Se and nutritional plane may impact placental function and fetal growth, as fetal weight and liver glycogen are altered despite similar placental vascularity measurements."
08/01/2006 - "In contrast, fetal weight was elevated by late GH treatment, and these fetuses had higher relative carcass fat content, perirenal fat mass, and liver glycogen concentrations than all other groups. "
01/01/1991 - "Fetal weight (3.61 vs. 2.86 kg) was decreased in the fasted group (p less than 0.001) while fetal hepatic glycogen was unchanged (59.8 vs. 52.4 mg/g tissue). "
08/01/1991 - "There was no effect of fetal "diabetes" on placental glycogen synthesis or on the distribution of placental glycogen between the maternal and fetal segments of the placenta, while it caused a marked decrease in the fetal liver glycogen content and fetal body weight. "
03/01/1982 - "3. Hepatic glycogen was extremely low in fatty liver and kidney syndrome-affected birds, whereas significant quantities remained in healthy birds up to at least 24 h post mortem."
05/01/1966 - "after administration, 1.0, 1.9 and 11.9% of the dose was recovered as liver glycogen, liver fatty acid and carcass fatty acid respectively. "
01/01/1995 - "For repeat dose studies, these included reduction in body weight gains, cushingoid syndrome in dogs, reductions in the numbers of lymphocytes and the weights of the tissues connected with the immune system, and hepatic glycogen deposition and fatty liver changes. "
08/01/2014 - "In 2000-2012, the main causes of diseases were liver degeneration (18.26%, 168/920), drug-induced liver injury (13.59%, 125/920), fatty liver (8.80%, 81/920) and liver glycogen accumulation disease (8.70%, 80/920). "
10/10/2011 - "Rubratoxicosis and fatty acid oxidation disorders (FAODs) share characteristic signs, such as robust appetite, hypoglycemia, hepatic glycogen depletion, and fatty liver. "
|3.||Blood Glucose (Blood Sugar)
|6.||Glucose-6-Phosphatase (Glucose 6 Phosphatase)
|8.||DNA (Deoxyribonucleic Acid)